Matches in Wikidata for { <http://www.wikidata.org/entity/Q66389037> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q66389037 description "clinical trial" @default.
- Q66389037 description "ensayu clínicu" @default.
- Q66389037 description "klinisch onderzoek" @default.
- Q66389037 description "клінічне випробування" @default.
- Q66389037 description "կլինիկական փորձարկում" @default.
- Q66389037 name "Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer" @default.
- Q66389037 name "Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer" @default.
- Q66389037 type Item @default.
- Q66389037 label "Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer" @default.
- Q66389037 label "Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer" @default.
- Q66389037 prefLabel "Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer" @default.
- Q66389037 prefLabel "Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer" @default.
- Q66389037 P1050 Q66389037-2596422A-7EE6-4939-822E-AC863019D5A2 @default.
- Q66389037 P1132 Q66389037-E150783F-3AD5-4240-B19B-9F076A78F7C9 @default.
- Q66389037 P1476 Q66389037-98B48A2A-CEC6-4E9F-8C8A-EA0DD24CE055 @default.
- Q66389037 P17 Q66389037-48D3306A-663C-496B-B359-0B7846604220 @default.
- Q66389037 P2899 Q66389037-9819AAFF-47D7-447C-9FB4-DEEAE3454CE4 @default.
- Q66389037 P3098 Q66389037-0CD01172-D4C5-4E1D-9CFB-08B188EA420C @default.
- Q66389037 P31 Q66389037-CB97D34F-A4A3-49E2-BA99-23DE430399CB @default.
- Q66389037 P580 Q66389037-84E299C8-90F6-482A-96A5-66FC8BC3E480 @default.
- Q66389037 P582 Q66389037-05A4A01C-76D1-4C41-A697-78CA1198F73A @default.
- Q66389037 P6099 Q66389037-9549386E-193A-48F1-BB2C-9B0D722FBA3B @default.
- Q66389037 P8363 Q66389037-16C9CFB2-869F-464E-809B-962EA0F0E05C @default.
- Q66389037 P859 Q66389037-A8FEE9ED-B3F0-4718-8452-DB5FB8C14FD1 @default.
- Q66389037 P1050 Q356033 @default.
- Q66389037 P1132 "+180" @default.
- Q66389037 P1476 "Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I)" @default.
- Q66389037 P17 Q30 @default.
- Q66389037 P2899 "+18" @default.
- Q66389037 P3098 "NCT04037254" @default.
- Q66389037 P31 Q30612 @default.
- Q66389037 P580 "2019-06-03T00:00:00Z" @default.
- Q66389037 P582 "2023-12-31T00:00:00Z" @default.
- Q66389037 P6099 Q42824440 @default.
- Q66389037 P8363 Q78089383 @default.
- Q66389037 P859 Q30270252 @default.